HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Natixis Advisors LLC

Natixis Advisors LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 110,105 shares of the company's stock after acquiring an additional 2,459 shares during the period. Natixis Advisors LLC's holdings in HCA Healthcare were worth $44,750,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Mizuho Securities USA LLC boosted its holdings in shares of HCA Healthcare by 205.4% in the third quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company's stock valued at $18,548,000 after acquiring an additional 30,693 shares in the last quarter. Simplify Asset Management Inc. lifted its position in shares of HCA Healthcare by 67.1% in the 3rd quarter. Simplify Asset Management Inc. now owns 2,351 shares of the company's stock worth $956,000 after buying an additional 944 shares during the last quarter. Valley Wealth Managers Inc. lifted its position in HCA Healthcare by 14.4% in the 3rd quarter. Valley Wealth Managers Inc. now owns 1,383 shares of the company's stock valued at $562,000 after purchasing an additional 174 shares during the last quarter. Empowered Funds LLC increased its position in shares of HCA Healthcare by 10.2% in the third quarter. Empowered Funds LLC now owns 21,824 shares of the company's stock worth $8,870,000 after acquiring an additional 2,019 shares in the last quarter. Finally, Empirical Finance LLC lifted its stake in shares of HCA Healthcare by 1.4% in the third quarter. Empirical Finance LLC now owns 7,232 shares of the company's stock worth $2,939,000 after buying an additional 98 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA stock traded down $7.07 on Monday, hitting $335.89. The company's stock had a trading volume of 1,496,181 shares, compared to its average volume of 1,187,725. The company has a market capitalization of $85.08 billion, a PE ratio of 15.40, a PEG ratio of 1.32 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $245.03 and a fifty-two week high of $417.14. The stock's 50 day moving average is $385.11 and its 200-day moving average is $357.92.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.79%. The ex-dividend date is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

Analysts Set New Price Targets

Several brokerages recently issued reports on HCA. Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Truist Financial lifted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a research note on Monday, August 19th. Barclays decreased their price target on HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating for the company in a report on Friday, November 8th. Royal Bank of Canada upped their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research report on Friday, August 23rd. Finally, Leerink Partners increased their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an "outperform" rating in a research report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $385.00.

Insider Transactions at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company's stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the business's stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 in the last ninety days. Company insiders own 1.60% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.